AVEO Pharmaceuticals, Inc. withdraws earnings guidance for the year 2022. Due to the pending transaction, the company will not host a conference call to discuss its quarterly financial results and withdraws its previously issued financial guidance for fiscal year 2022, last updated on August 4, 2022.
1st Jan change | Capi. | |
---|---|---|
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-13.96% | 15.36B | |
-8.82% | 11.95B | |
-15.91% | 11.6B | |
-43.00% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |